Radiotherapy/Radiation / Akt Cancer Research Results
Rad, Radiotherapy/Radiation: Click to Expand ⟱
| Features: |
Treatment of disease with radiation, especially by selective irradiation with x-rays or other ionizing radiation and by ingestion of radioisotopes.
Radiosensitizer
Atorvaqone, (mitochondria inhibitor) decrease O2 consumption making more O2 available as a radiosensitizer.
-Hypoxia (low oxygen levels) within tumors is a major cause of resistance to radiotherapy
|
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
Scientific Papers found: Click to Expand⟱
ChemoSen↑, NF-kB↓, *STAT3↓, *COX2↓, *Akt↓, *NRF2↑, *HO-1↑, *GPx↑, *NADPH↑, *GSH↑, *ROS↓, *p300↓, radioP↑, chemoP↑, RadioS↑,
HSP90↓, Akt↓, RadioS↑, selectivity↑,
*cognitive↑, *radioP↑, *ROS↓, *p‑Akt↑, *Bcl-2↑, *Mst1↓, *p‑p38↓, *JNK↓, *cl‑Casp3↓, *BAX↓,
TumCP↓, Apoptosis↑, TumCMig↓, RadioS↑, TumCCA↑, PI3K↓, p‑Akt↓, PDK1↓,
tumCV↓, ROS↑, Casp3↑, p‑Akt↓, Akt↓, MMP2↓, P21↓,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Nor, |
PrEC |
|
|
|
selectivity↑, RadioS↑, ROS↑, *ROS∅, NADPH↑, Trx↓, PI3K↑, Akt↑, p‑FOXO3↓, SOD2↓, Catalase↓, radioP↑, *NADPH∅, *GSH↑, *GSH/GSSG↑, *NRF2↑,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↓, 1, ROS↑, 2, SOD2↓, 1, Trx↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
NADPH↑, 1, PDK1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 2, Akt↑, 1, p‑Akt↓, 2, Apoptosis↑, 1, Casp3↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP90↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑FOXO3↓, 1, PI3K↓, 1, PI3K↑, 1,
Migration(tgid=13) ⓘ
MMP2↓, 1, TumCMig↓, 1, TumCP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, RadioS↑, 4, selectivity↑, 2,
Functional Outcomes(tgid=23) ⓘ
chemoP↑, 1, radioP↑, 2,
Total Targets: 27
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GPx↑, 1, GSH↑, 2, GSH/GSSG↑, 1, HO-1↑, 1, NRF2↑, 2, ROS↓, 2, ROS∅, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
NADPH↑, 1, NADPH∅, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, p‑Akt↑, 1, BAX↓, 1, Bcl-2↑, 1, cl‑Casp3↓, 1, JNK↓, 1, p‑p38↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Mst1↓, 1, p300↓, 1, STAT3↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1,
Functional Outcomes(tgid=23) ⓘ
cognitive↑, 1, radioP↑, 1,
Total Targets: 22
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:201 Target#:4 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page